Global Rotavirus Vaccines Market Growth 2020-2025
According to this study, over the next five years the Rotavirus Vaccines market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Rotavirus Vaccines business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Rotavirus Vaccines market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Rotavirus Vaccines, covering the supply chain analysis, impact assessment to the Rotavirus Vaccines market size growth rate in several scenarios, and the measures to be undertaken by Rotavirus Vaccines companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Adult
Pediatric
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bharat Biotech
Merck & Co., Inc
Lanzhou Institute of Biological
Bharat Biotech International Limited
GlaxoSmithKline plc
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Rotavirus Vaccines consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Rotavirus Vaccines market by identifying its various subsegments.
Focuses on the key global Rotavirus Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Rotavirus Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Rotavirus Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rotavirus Vaccines Consumption 2015-2025
2.1.2 Rotavirus Vaccines Consumption CAGR by Region
2.2 Rotavirus Vaccines Segment by Type
2.2.1 Rotarix
2.2.2 RotaTeq
2.2.3 Rotavac
2.2.4 Rotavin-M1
2.2.5 Lanzhou lamb
2.2.6 Others
2.3 Rotavirus Vaccines Consumption by Type
2.3.1 Global Rotavirus Vaccines Consumption Market Share by Type (2015-2020)
2.3.2 Global Rotavirus Vaccines Revenue and Market Share by Type (2015-2020)
2.3.3 Global Rotavirus Vaccines Sale Price by Type (2015-2020)
2.4 Rotavirus Vaccines Segment by Application
2.4.1 Adult
2.4.2 Pediatric
2.5 Rotavirus Vaccines Consumption by Application
2.5.1 Global Rotavirus Vaccines Consumption Market Share by Type (2015-2020)
2.5.2 Global Rotavirus Vaccines Value and Market Share by Type (2015-2020)
2.5.3 Global Rotavirus Vaccines Sale Price by Type (2015-2020)
3 Global Rotavirus Vaccines by Company
3.1 Global Rotavirus Vaccines Sales Market Share by Company
3.1.1 Global Rotavirus Vaccines Sales by Company (2018-2020)
3.1.2 Global Rotavirus Vaccines Sales Market Share by Company (2018-2020)
3.2 Global Rotavirus Vaccines Revenue Market Share by Company
3.2.1 Global Rotavirus Vaccines Revenue by Company (2018-2020)
3.2.2 Global Rotavirus Vaccines Revenue Market Share by Company (2018-2020)
3.3 Global Rotavirus Vaccines Sale Price by Company
3.4 Global Rotavirus Vaccines Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Rotavirus Vaccines Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Rotavirus Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Rotavirus Vaccines by Regions
4.1 Rotavirus Vaccines by Regions
4.2 Americas Rotavirus Vaccines Consumption Growth
4.3 APAC Rotavirus Vaccines Consumption Growth
4.4 Europe Rotavirus Vaccines Consumption Growth
4.5 Middle East & Africa Rotavirus Vaccines Consumption Growth
5 Americas
5.1 Americas Rotavirus Vaccines Consumption by Countries
5.1.1 Americas Rotavirus Vaccines Consumption by Countries (2015-2020)
5.1.2 Americas Rotavirus Vaccines Value by Countries (2015-2020)
5.2 Americas Rotavirus Vaccines Consumption by Type
5.3 Americas Rotavirus Vaccines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Rotavirus Vaccines Consumption by Regions
6.1.1 APAC Rotavirus Vaccines Consumption by Regions (2015-2020)
6.1.2 APAC Rotavirus Vaccines Value by Regions (2015-2020)
6.2 APAC Rotavirus Vaccines Consumption by Type
6.3 APAC Rotavirus Vaccines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Rotavirus Vaccines by Countries
7.1.1 Europe Rotavirus Vaccines Consumption by Countries (2015-2020)
7.1.2 Europe Rotavirus Vaccines Value by Countries (2015-2020)
7.2 Europe Rotavirus Vaccines Consumption by Type
7.3 Europe Rotavirus Vaccines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Rotavirus Vaccines by Countries
8.1.1 Middle East & Africa Rotavirus Vaccines Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Rotavirus Vaccines Value by Countries (2015-2020)
8.2 Middle East & Africa Rotavirus Vaccines Consumption by Type
8.3 Middle East & Africa Rotavirus Vaccines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Rotavirus Vaccines Distributors
10.3 Rotavirus Vaccines Customer
11 Global Rotavirus Vaccines Market Forecast
11.1 Global Rotavirus Vaccines Consumption Forecast (2021-2025)
11.2 Global Rotavirus Vaccines Forecast by Regions
11.2.1 Global Rotavirus Vaccines Forecast by Regions (2021-2025)
11.2.2 Global Rotavirus Vaccines Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Rotavirus Vaccines Forecast by Type
11.8 Global Rotavirus Vaccines Forecast by Application
12 Key Players Analysis
12.1 Bharat Biotech
12.1.1 Company Information
12.1.2 Rotavirus Vaccines Product Offered
12.1.3 Bharat Biotech Rotavirus Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Bharat Biotech Latest Developments
12.2 Merck & Co., Inc
12.2.1 Company Information
12.2.2 Rotavirus Vaccines Product Offered
12.2.3 Merck & Co., Inc Rotavirus Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Merck & Co., Inc Latest Developments
12.3 Lanzhou Institute of Biological
12.3.1 Company Information
12.3.2 Rotavirus Vaccines Product Offered
12.3.3 Lanzhou Institute of Biological Rotavirus Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Lanzhou Institute of Biological Latest Developments
12.4 Bharat Biotech International Limited
12.4.1 Company Information
12.4.2 Rotavirus Vaccines Product Offered
12.4.3 Bharat Biotech International Limited Rotavirus Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Bharat Biotech International Limited Latest Developments
12.5 GlaxoSmithKline plc
12.5.1 Company Information
12.5.2 Rotavirus Vaccines Product Offered
12.5.3 GlaxoSmithKline plc Rotavirus Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 GlaxoSmithKline plc Latest Developments
...
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Rotavirus Vaccines Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Rotarix
Table 5. Major Players of RotaTeq
Table 6. Major Players of Rotavac
Table 7. Major Players of Rotavin-M1
Table 8. Major Players of Lanzhou lamb
Table 9. Major Players of Others
Table 10. Global Consumption Sales by Type (2015-2020)
Table 11. Global Rotavirus Vaccines Consumption Market Share by Type (2015-2020)
Table 12. Global Rotavirus Vaccines Revenue by Type (2015-2020) ($ million)
Table 13. Global Rotavirus Vaccines Value Market Share by Type (2015-2020) ($ Millions)
Table 14. Global Rotavirus Vaccines Sale Price by Type (2015-2020)
Table 15. Global Consumption Sales by Application (2015-2020)
Table 16. Global Rotavirus Vaccines Consumption Market Share by Application (2015-2020)
Table 17. Global Rotavirus Vaccines Value by Application (2015-2020)
Table 18. Global Rotavirus Vaccines Value Market Share by Application (2015-2020)
Table 19. Global Rotavirus Vaccines Sale Price by Application (2015-2020)
Table 20. Global Rotavirus Vaccines Sales by Company (2017-2019) (K Units)
Table 21. Global Rotavirus Vaccines Sales Market Share by Company (2017-2019)
Table 22. Global Rotavirus Vaccines Revenue by Company (2017-2019) ($ Millions)
Table 23. Global Rotavirus Vaccines Revenue Market Share by Company (2017-2019)
Table 24. Global Rotavirus Vaccines Sale Price by Company (2017-2019)
Table 25. Global Rotavirus Vaccines Manufacturing Base Distribution and Sales Area by Manufacturers
Table 26. Players Rotavirus Vaccines Products Offered
Table 27. Rotavirus Vaccines Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 28. Global Rotavirus Vaccines Consumption by Regions 2015-2020 (K Units)
Table 29. Global Rotavirus Vaccines Consumption Market Share by Regions 2015-2020
Table 30. Global Rotavirus Vaccines Value by Regions 2015-2020 ($ Millions)
Table 31. Global Rotavirus Vaccines Value Market Share by Regions 2015-2020
Table 32. Americas Rotavirus Vaccines Consumption by Countries (2015-2020) (K Units)
Table 33. Americas Rotavirus Vaccines Consumption Market Share by Countries (2015-2020)
Table 34. Americas Rotavirus Vaccines Value by Countries (2015-2020) ($ Millions)
Table 35. Americas Rotavirus Vaccines Value Market Share by Countries (2015-2020)
Table 36. Americas Rotavirus Vaccines Consumption by Type (2015-2020) (K Units)
Table 37. Americas Rotavirus Vaccines Consumption Market Share by Type (2015-2020)
Table 38. Americas Rotavirus Vaccines Consumption by Application (2015-2020) (K Units)
Table 39. Americas Rotavirus Vaccines Consumption Market Share by Application (2015-2020)
Table 40. APAC Rotavirus Vaccines Consumption by Regions (2015-2020) (K Units)
Table 41. APAC Rotavirus Vaccines Consumption Market Share by Regions (2015-2020)
Table 42. APAC Rotavirus Vaccines Value by Regions (2015-2020) ($ Millions)
Table 43. APAC Rotavirus Vaccines Value Market Share by Regions (2015-2020)
Table 44. APAC Rotavirus Vaccines Consumption by Type (2015-2020) (K Units)
Table 45. APAC Rotavirus Vaccines Consumption Market Share by Type (2015-2020)
Table 46. APAC Rotavirus Vaccines Consumption by Application (2015-2020) (K Units)
Table 47. APAC Rotavirus Vaccines Consumption Market Share by Application (2015-2020)
Table 48. Europe Rotavirus Vaccines Consumption by Countries (2015-2020) (K Units)
Table 49. Europe Rotavirus Vaccines Consumption Market Share by Countries (2015-2020)
Table 50. Europe Rotavirus Vaccines Value by Countries (2015-2020) ($ Millions)
Table 51. Europe Rotavirus Vaccines Value Market Share by Countries (2015-2020)
Table 52. Europe Rotavirus Vaccines Consumption by Type (2015-2020) (K Units)
Table 53. Europe Rotavirus Vaccines Consumption Market Share by Type (2015-2020)
Table 54. Europe Rotavirus Vaccines Consumption by Application (2015-2020) (K Units)
Table 55. Europe Rotavirus Vaccines Consumption Market Share by Application (2015-2020)
Table 56. Middle East & Africa Rotavirus Vaccines Consumption by Countries (2015-2020) (K Units)
Table 57. Middle East & Africa Rotavirus Vaccines Consumption Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Rotavirus Vaccines Value by Countries (2015-2020) ($ Millions)
Table 59. Middle East & Africa Rotavirus Vaccines Value Market Share by Countries (2015-2020)
Table 60. Middle East & Africa Rotavirus Vaccines Consumption by Type (2015-2020) (K Units)
Table 61. Middle East & Africa Rotavirus Vaccines Consumption Market Share by Type (2015-2020)
Table 62. Middle East & Africa Rotavirus Vaccines Consumption by Application (2015-2020) (K Units)
Table 63. Middle East & Africa Rotavirus Vaccines Consumption Market Share by Application (2015-2020)
Table 64. Rotavirus Vaccines Distributors List
Table 65. Rotavirus Vaccines Customer List
Table 66. Global Rotavirus Vaccines Consumption Forecast by Countries (2021-2025) (K Units)
Table 67. Global Rotavirus Vaccines Consumption Market Forecast by Regions
Table 68. Global Rotavirus Vaccines Value Forecast by Countries (2021-2025) ($ Millions)
Table 69. Global Rotavirus Vaccines Value Market Share Forecast by Regions
Table 70. Global Rotavirus Vaccines Consumption Forecast by Type (2021-2025) (K Units)
Table 71. Global Rotavirus Vaccines Consumption Market Share Forecast by Type (2021-2025)
Table 72. Global Rotavirus Vaccines Value Forecast by Type (2021-2025) ($ Millions)
Table 73. Global Rotavirus Vaccines Value Market Share Forecast by Type (2021-2025)
Table 74. Global Rotavirus Vaccines Consumption Forecast by Application (2021-2025) (K Units)
Table 75. Global Rotavirus Vaccines Consumption Market Share Forecast by Application (2021-2025)
Table 76. Global Rotavirus Vaccines Value Forecast by Application (2021-2025) ($ Millions)
Table 77. Global Rotavirus Vaccines Value Market Share Forecast by Application (2021-2025)
Table 78. Bharat Biotech Product Offered
Table 79. Bharat Biotech Rotavirus Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 80. Bharat Biotech Main Business
Table 81. Bharat Biotech Latest Developments
Table 82. Bharat Biotech Basic Information, Company Total Revenue (in $ million), Rotavirus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck & Co., Inc Product Offered
Table 84. Merck & Co., Inc Rotavirus Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 85. Merck & Co., Inc Main Business
Table 86. Merck & Co., Inc Latest Developments
Table 87. Merck & Co., Inc Basic Information, Company Total Revenue (in $ million), Rotavirus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 88. Lanzhou Institute of Biological Product Offered
Table 89. Lanzhou Institute of Biological Rotavirus Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 90. Lanzhou Institute of Biological Main Business
Table 91. Lanzhou Institute of Biological Latest Developments
Table 92. Lanzhou Institute of Biological Basic Information, Company Total Revenue (in $ million), Rotavirus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. Bharat Biotech International Limited Product Offered
Table 94. Bharat Biotech International Limited Rotavirus Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 95. Bharat Biotech International Limited Main Business
Table 96. Bharat Biotech International Limited Latest Developments
Table 97. Bharat Biotech International Limited Basic Information, Company Total Revenue (in $ million), Rotavirus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. GlaxoSmithKline plc Product Offered
Table 99. GlaxoSmithKline plc Rotavirus Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 100. GlaxoSmithKline plc Main Business
Table 101. GlaxoSmithKline plc Latest Developments
Table 102. GlaxoSmithKline plc Basic Information, Company Total Revenue (in $ million), Rotavirus Vaccines Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Rotavirus Vaccines
Figure 2. Rotavirus Vaccines Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Rotavirus Vaccines Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Rotavirus Vaccines Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Rotarix
Figure 7. Product Picture of RotaTeq
Figure 8. Product Picture of Rotavac
Figure 9. Product Picture of Rotavin-M1
Figure 10. Product Picture of Lanzhou lamb
Figure 11. Product Picture of Others
Figure 12. Global Rotavirus Vaccines Consumption Market Share by Type (2015-2020)
Figure 13. Global Rotavirus Vaccines Value Market Share by Type (2015-2020)
Figure 14. Rotavirus Vaccines Consumed in Adult
Figure 15. Global Rotavirus Vaccines Market: Adult (2015-2020) (K Units)
Figure 16. Global Rotavirus Vaccines Market: Adult (2015-2020) ($ Millions)
Figure 17. Rotavirus Vaccines Consumed in Pediatric
Figure 18. Global Rotavirus Vaccines Market: Pediatric (2015-2020) (K Units)
Figure 19. Global Rotavirus Vaccines Market: Pediatric (2015-2020) ($ Millions)
Figure 20. Global Rotavirus Vaccines Consumption Market Share by Application (2015-2020)
Figure 21. Global Rotavirus Vaccines Value Market Share by Application (2015-2020)
Figure 22. Global Rotavirus Vaccines Sales Market Share by Company in 2017
Figure 23. Global Rotavirus Vaccines Sales Market Share by Company in 2019
Figure 24. Global Rotavirus Vaccines Revenue Market Share by Company in 2017
Figure 25. Global Rotavirus Vaccines Revenue Market Share by Company in 2019
Figure 26. Global Rotavirus Vaccines Sale Price by Company in 2019
Figure 27. Global Rotavirus Vaccines Consumption Market Share by Regions 2015-2020
Figure 28. Global Rotavirus Vaccines Value Market Share by Regions 2015-2020
Figure 29. Americas Rotavirus Vaccines Consumption 2015-2020 (K Units)
Figure 30. Americas Rotavirus Vaccines Value 2015-2020 ($ Millions)
Figure 31. APAC Rotavirus Vaccines Consumption 2015-2020 (K Units)
Figure 32. APAC Rotavirus Vaccines Value 2015-2020 ($ Millions)
Figure 33. Europe Rotavirus Vaccines Consumption 2015-2020 (K Units)
Figure 34. Europe Rotavirus Vaccines Value 2015-2020 ($ Millions)
Figure 35. Middle East & Africa Rotavirus Vaccines Consumption 2015-2020 (K Units)
Figure 36. Middle East & Africa Rotavirus Vaccines Value 2015-2020 ($ Millions)
Figure 37. Americas Rotavirus Vaccines Consumption Market Share by Countries in 2019
Figure 38. Americas Rotavirus Vaccines Value Market Share by Countries in 2019
Figure 39. Americas Rotavirus Vaccines Consumption Market Share by Type in 2019
Figure 40. Americas Rotavirus Vaccines Consumption Market Share by Application in 2019
Figure 41. United States Rotavirus Vaccines Consumption Growth 2015-2020 (K Units)
Figure 42. United States Rotavirus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 43. Canada Rotavirus Vaccines Consumption Growth 2015-2020 (K Units)
Figure 44. Canada Rotavirus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 45. Mexico Rotavirus Vaccines Consumption Growth 2015-2020 (K Units)
Figure 46. Mexico Rotavirus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 47. APAC Rotavirus Vaccines Consumption Market Share by Countries in 2019
Figure 48. APAC Rotavirus Vaccines Value Market Share by Regions in 2019
Figure 49. APAC Rotavirus Vaccines Consumption Market Share by Type in 2019
Figure 50. APAC Rotavirus Vaccines Consumption Market Share by Application in 2019
Figure 51. China Rotavirus Vaccines Consumption Growth 2015-2020 (K Units)
Figure 52. China Rotavirus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 53. Japan Rotavirus Vaccines Consumption Growth 2015-2020 (K Units)
Figure 54. Japan Rotavirus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 55. Korea Rotavirus Vaccines Consumption Growth 2015-2020 (K Units)
Figure 56. Korea Rotavirus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 57. Southeast Asia Rotavirus Vaccines Consumption Growth 2015-2020 (K Units)
Figure 58. Southeast Asia Rotavirus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 59. India Rotavirus Vaccines Consumption Growth 2015-2020 (K Units)
Figure 60. India Rotavirus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 61. Australia Rotavirus Vaccines Consumption Growth 2015-2020 (K Units)
Figure 62. Australia Rotavirus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 63. Europe Rotavirus Vaccines Consumption Market Share by Countries in 2019
Figure 64. Europe Rotavirus Vaccines Value Market Share by Countries in 2019
Figure 65. Europe Rotavirus Vaccines Consumption Market Share by Type in 2019
Figure 66. Europe Rotavirus Vaccines Consumption Market Share by Application in 2019
Figure 67. Germany Rotavirus Vaccines Consumption Growth 2015-2020 (K Units)
Figure 68. Germany Rotavirus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 69. France Rotavirus Vaccines Consumption Growth 2015-2020 (K Units)
Figure 70. France Rotavirus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 71. UK Rotavirus Vaccines Consumption Growth 2015-2020 (K Units)
Figure 72. UK Rotavirus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 73. Italy Rotavirus Vaccines Consumption Growth 2015-2020 (K Units)
Figure 74. Italy Rotavirus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 75. Russia Rotavirus Vaccines Consumption Growth 2015-2020 (K Units)
Figure 76. Russia Rotavirus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 77. Middle East & Africa Rotavirus Vaccines Consumption Market Share by Countries in 2019
Figure 78. Middle East & Africa Rotavirus Vaccines Value Market Share by Countries in 2019
Figure 79. Middle East & Africa Rotavirus Vaccines Consumption Market Share by Type in 2019
Figure 80. Middle East & Africa Rotavirus Vaccines Consumption Market Share by Application in 2019
Figure 81. Egypt Rotavirus Vaccines Consumption Growth 2015-2020 (K Units)
Figure 82. Egypt Rotavirus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 83. South Africa Rotavirus Vaccines Consumption Growth 2015-2020 (K Units)
Figure 84. South Africa Rotavirus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 85. Israel Rotavirus Vaccines Consumption Growth 2015-2020 (K Units)
Figure 86. Israel Rotavirus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 87. Turkey Rotavirus Vaccines Consumption Growth 2015-2020 (K Units)
Figure 88. Turkey Rotavirus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 89. GCC Countries Rotavirus Vaccines Consumption Growth 2015-2020 (K Units)
Figure 90. GCC Countries Rotavirus Vaccines Value Growth 2015-2020 ($ Millions)
Figure 91. Global Rotavirus Vaccines Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 92. Global Rotavirus Vaccines Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 93. Americas Rotavirus Vaccines Consumption 2021-2025 (K Units)
Figure 94. Americas Rotavirus Vaccines Value 2021-2025 ($ Millions)
Figure 95. APAC Rotavirus Vaccines Consumption 2021-2025 (K Units)
Figure 96. APAC Rotavirus Vaccines Value 2021-2025 ($ Millions)
Figure 97. Europe Rotavirus Vaccines Consumption 2021-2025 (K Units)
Figure 98. Europe Rotavirus Vaccines Value 2021-2025 ($ Millions)
Figure 99. Middle East & Africa Rotavirus Vaccines Consumption 2021-2025 (K Units)
Figure 100. Middle East & Africa Rotavirus Vaccines Value 2021-2025 ($ Millions)
Figure 101. United States Rotavirus Vaccines Consumption 2021-2025 (K Units)
Figure 102. United States Rotavirus Vaccines Value 2021-2025 ($ Millions)
Figure 103. Canada Rotavirus Vaccines Consumption 2021-2025 (K Units)
Figure 104. Canada Rotavirus Vaccines Value 2021-2025 ($ Millions)
Figure 105. Mexico Rotavirus Vaccines Consumption 2021-2025 (K Units)
Figure 106. Mexico Rotavirus Vaccines Value 2021-2025 ($ Millions)
Figure 107. Brazil Rotavirus Vaccines Consumption 2021-2025 (K Units)
Figure 108. Brazil Rotavirus Vaccines Value 2021-2025 ($ Millions)
Figure 109. China Rotavirus Vaccines Consumption 2021-2025 (K Units)
Figure 110. China Rotavirus Vaccines Value 2021-2025 ($ Millions)
Figure 111. Japan Rotavirus Vaccines Consumption 2021-2025 (K Units)
Figure 112. Japan Rotavirus Vaccines Value 2021-2025 ($ Millions)
Figure 113. Korea Rotavirus Vaccines Consumption 2021-2025 (K Units)
Figure 114. Korea Rotavirus Vaccines Value 2021-2025 ($ Millions)
Figure 115. Southeast Asia Rotavirus Vaccines Consumption 2021-2025 (K Units)
Figure 116. Southeast Asia Rotavirus Vaccines Value 2021-2025 ($ Millions)
Figure 117. India Rotavirus Vaccines Consumption 2021-2025 (K Units)
Figure 118. India Rotavirus Vaccines Value 2021-2025 ($ Millions)
Figure 119. Australia Rotavirus Vaccines Consumption 2021-2025 (K Units)
Figure 120. Australia Rotavirus Vaccines Value 2021-2025 ($ Millions)
Figure 121. Germany Rotavirus Vaccines Consumption 2021-2025 (K Units)
Figure 122. Germany Rotavirus Vaccines Value 2021-2025 ($ Millions)
Figure 123. France Rotavirus Vaccines Consumption 2021-2025 (K Units)
Figure 124. France Rotavirus Vaccines Value 2021-2025 ($ Millions)
Figure 125. UK Rotavirus Vaccines Consumption 2021-2025 (K Units)
Figure 126. UK Rotavirus Vaccines Value 2021-2025 ($ Millions)
Figure 127. Italy Rotavirus Vaccines Consumption 2021-2025 (K Units)
Figure 128. Italy Rotavirus Vaccines Value 2021-2025 ($ Millions)
Figure 129. Russia Rotavirus Vaccines Consumption 2021-2025 (K Units)
Figure 130. Russia Rotavirus Vaccines Value 2021-2025 ($ Millions)
Figure 131. Spain Rotavirus Vaccines Consumption 2021-2025 (K Units)
Figure 132. Spain Rotavirus Vaccines Value 2021-2025 ($ Millions)
Figure 133. Egypt Rotavirus Vaccines Consumption 2021-2025 (K Units)
Figure 134. Egypt Rotavirus Vaccines Value 2021-2025 ($ Millions)
Figure 135. South Africa Rotavirus Vaccines Consumption 2021-2025 (K Units)
Figure 136. South Africa Rotavirus Vaccines Value 2021-2025 ($ Millions)
Figure 137. Israel Rotavirus Vaccines Consumption 2021-2025 (K Units)
Figure 138. Israel Rotavirus Vaccines Value 2021-2025 ($ Millions)
Figure 139. Turkey Rotavirus Vaccines Consumption 2021-2025 (K Units)
Figure 140. Turkey Rotavirus Vaccines Value 2021-2025 ($ Millions)
Figure 141. GCC Countries Rotavirus Vaccines Consumption 2021-2025 (K Units)
Figure 142. GCC Countries Rotavirus Vaccines Value 2021-2025 ($ Millions)
Figure 143. Bharat Biotech Rotavirus Vaccines Market Share (2018-2020)
Figure 144. Merck & Co., Inc Rotavirus Vaccines Market Share (2018-2020)
Figure 145. Lanzhou Institute of Biological Rotavirus Vaccines Market Share (2018-2020)
Figure 146. Bharat Biotech International Limited Rotavirus Vaccines Market Share (2018-2020)
Figure 147. GlaxoSmithKline plc Rotavirus Vaccines Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets